Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Jaz Dhillon

MRPharmS

Recent stories

  • Meldonium, the drug that shook tennis and the sporting worldSubscription

    15 MAR 2016

    Meldonium has sent shockwaves through the tennis world and beyond after tennis player Maria Sharapova hit the headlines after testing positive for the recently banned substance at the 2016 Australian Open. Sold under the brand name Mildronate, meldonium is an anti-ischaemic drug developed at the Latvian Institute of Organic Synthesis and was designed to inhibit carnitine biosynthesis in order to prevent accumulation of cytotoxic intermediate products of fatty acid beta-oxidation in isc

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.